Initial Statement of Beneficial Ownership

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2008 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*
Steiner Solomon
2. Date of Event Requiring Statement (MM/DD/YYYY) 5/10/2007
3. Issuer Name and Ticker or Trading Symbol
Biodel Inc [BIOD]

(Last)        (First)        (Middle)
C/O BIODEL INC., 6 CHRISTOPHER COLUMBUS AVE.
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director                            ___ X ___ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
President and CEO /

(Street)
DANBURY, CT 06810

(City)              (State)              (Zip) 5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security
(Instr. 4) 2. Amount of Securities Beneficially Owned
(Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Common Stock 53110 D

Common Stock 4136707 I See footnote ⁽¹⁾

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)

1. Title of Derivate Security
(Instr. 4) 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 6. Nature of Indirect Beneficial Ownership
(Instr. 5)

Date Exercisable Expiration Date Title Amount or Number of Shares

Employee Stock Option (right to buy) ⁽²⁾ 12/22/2012 Common Stock 53138 $1.41 D

Employee Stock Option (right to buy) ⁽³⁾ 12/14/2013 Common Stock 53138 $5.65 D

Employee Stock Option (right to buy) ⁽⁴⁾ 12/18/2014 Common Stock 53138 $12.63 D

Series B Convertible Preferred Stock ⁽⁵⁾ ⁽⁵⁾ Common Stock 94449 ⁽⁵⁾ D

Explanation of Responses:

( 1) The amount shown represents the beneficial ownership of the Issuer's securities held by Steiner Ventures, LLC, which may be deemed attributable to the Reporting Person who is the sole managing member of Steiner Venturer, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent his pecuniary interest therein.

( 2) This option is exercisable in four equal installments. The first two installments became exercisable on December 23, 2005 and December 23, 2006 and the next two installments become exercisable on December 23, 2007 and December 23, 2008.

( 3) This option is exercisable in four equal installments. The first installment became exercisable on December 15, 2006 and the next three installments become exercisable on December 15, 2007, 2008 and 2009.

( 4) This option is exercisable in four equal installments on December 19, 2007, 2008, 2009 and 2010.

( 5) The Series B Convertible Preferred Stock has no expiration date. It is immediately convertible and will automatically convert into Common Stock of the Issuer upon the close of the Issuer's initial public offering on a one for one basis.

Reporting Owners

Reporting Owner Name / Address Relationships

Director 10% Owner Officer Other

Steiner Solomon
C/O BIODEL INC.
6 CHRISTOPHER COLUMBUS AVE.
DANBURY, CT 06810 X X President and CEO

Signatures

/s/ Solomon S. Steiner 5/10/2007

^** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	53110	D
Common Stock	4136707	I	See footnote ⁽¹⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽²⁾	12/22/2012	Common Stock	53138	$1.41	D
Employee Stock Option (right to buy)	⁽³⁾	12/14/2013	Common Stock	53138	$5.65	D
Employee Stock Option (right to buy)	⁽⁴⁾	12/18/2014	Common Stock	53138	$12.63	D
Series B Convertible Preferred Stock	⁽⁵⁾	⁽⁵⁾	Common Stock	94449	⁽⁵⁾	D

Explanation of Responses:
( 1)	The amount shown represents the beneficial ownership of the Issuer's securities held by Steiner Ventures, LLC, which may be deemed attributable to the Reporting Person who is the sole managing member of Steiner Venturer, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent his pecuniary interest therein.
( 2)	This option is exercisable in four equal installments. The first two installments became exercisable on December 23, 2005 and December 23, 2006 and the next two installments become exercisable on December 23, 2007 and December 23, 2008.
( 3)	This option is exercisable in four equal installments. The first installment became exercisable on December 15, 2006 and the next three installments become exercisable on December 15, 2007, 2008 and 2009.
( 4)	This option is exercisable in four equal installments on December 19, 2007, 2008, 2009 and 2010.
( 5)	The Series B Convertible Preferred Stock has no expiration date. It is immediately convertible and will automatically convert into Common Stock of the Issuer upon the close of the Issuer's initial public offering on a one for one basis.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Steiner Solomon C/O BIODEL INC. 6 CHRISTOPHER COLUMBUS AVE. DANBURY, CT 06810	X	X	President and CEO

Signatures
/s/ Solomon S. Steiner		5/10/2007
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.